U.S. markets closed
  • S&P 500

    3,819.72
    -50.57 (-1.31%)
     
  • Dow 30

    31,270.09
    -121.43 (-0.39%)
     
  • Nasdaq

    12,997.75
    -361.04 (-2.70%)
     
  • Russell 2000

    2,207.79
    -23.72 (-1.06%)
     
  • Crude Oil

    61.00
    -0.28 (-0.46%)
     
  • Gold

    1,708.50
    -7.30 (-0.43%)
     
  • Silver

    26.15
    -0.24 (-0.90%)
     
  • EUR/USD

    1.2053
    -0.0035 (-0.29%)
     
  • 10-Yr Bond

    1.4700
    +0.0550 (+3.89%)
     
  • GBP/USD

    1.3935
    -0.0022 (-0.16%)
     
  • USD/JPY

    107.0700
    +0.3600 (+0.34%)
     
  • BTC-USD

    50,741.97
    +2,932.33 (+6.13%)
     
  • CMC Crypto 200

    1,014.06
    +25.96 (+2.63%)
     
  • FTSE 100

    6,675.47
    +61.72 (+0.93%)
     
  • Nikkei 225

    29,559.10
    +150.93 (+0.51%)
     

Biomarin Pharmaceutical Inc (BMRN) CEO Jean Jacques Bienaime Sold $595,560 of Shares

GuruFocus.com
·1 min read

- By insider

CEO of Biomarin Pharmaceutical Inc (30-Year Financial, Insider Trades) Jean Jacques Bienaime (insider trades) sold 7,000 shares of BMRN on 02/18/2021 at an average price of $85.08 a share. The total sale was $595,560.


Biomarin Pharmaceutical Inc is on rare-disease therapies. It develops and commercializes pharmaceuticals for serious diseases and medical conditions. Biomarin Pharmaceutical Inc has a market cap of $14.84 billion; its shares were traded at around $81.760000 with a P/E ratio of 18.71 and P/S ratio of 8.17. GuruFocus has detected 2 severe warning signs with Biomarin Pharmaceutical Inc. .

CEO Recent Trades:

  • CEO Jean Jacques Bienaime sold 7,000 shares of BMRN stock on 02/18/2021 at the average price of $85.08. The price of the stock has decreased by 3.9% since.

  • CEO Jean Jacques Bienaime sold 8,000 shares of BMRN stock on 02/17/2021 at the average price of $84.54. The price of the stock has decreased by 3.29% since.

  • CEO Jean Jacques Bienaime sold 16,667 shares of BMRN stock on 01/29/2021 at the average price of $82.79. The price of the stock has decreased by 1.24% since.

  • CEO Jean Jacques Bienaime sold 8,333 shares of BMRN stock on 01/27/2021 at the average price of $85.49. The price of the stock has decreased by 4.36% since.

Directors and Officers Recent Trades:

  • Director V Bryan Lawlis sold 7,500 shares of BMRN stock on 02/16/2021 at the average price of $87.41. The price of the stock has decreased by 6.46% since.

For the complete insider trading history of BMRN, click here

.This article first appeared on GuruFocus.